Jing Deng

807 total citations
22 papers, 643 citations indexed

About

Jing Deng is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jing Deng has authored 22 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jing Deng's work include Immune Cell Function and Interaction (3 papers), Oral microbiology and periodontitis research (3 papers) and Probiotics and Fermented Foods (2 papers). Jing Deng is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Oral microbiology and periodontitis research (3 papers) and Probiotics and Fermented Foods (2 papers). Jing Deng collaborates with scholars based in China, Saudi Arabia and United States. Jing Deng's co-authors include Qihui Zhou, Qiu Xia Ji, Yanjing Ji, Rui Lü, Qing Zhao, Changqing Yuan, Min Li, Wenwen Zhao, Peng Zhao and Yun He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carbohydrate Polymers and Annals of Oncology.

In The Last Decade

Jing Deng

22 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Deng China 10 145 106 99 95 91 22 643
Changqing Yuan China 13 143 1.0× 145 1.4× 135 1.4× 87 0.9× 102 1.1× 25 580
Gaurav Baranwal India 12 99 0.7× 142 1.3× 54 0.5× 76 0.8× 87 1.0× 20 530
Aimee E. Krausz United States 12 143 1.0× 104 1.0× 166 1.7× 54 0.6× 76 0.8× 25 754
Farzaneh Pakdel Iran 10 177 1.2× 87 0.8× 54 0.5× 30 0.3× 130 1.4× 27 612
Yanjing Ji China 9 170 1.2× 100 0.9× 164 1.7× 89 0.9× 132 1.5× 10 547
Hosein Eslami Iran 10 205 1.4× 93 0.9× 64 0.6× 32 0.3× 152 1.7× 37 749
S Shanmuganathan India 15 272 1.9× 84 0.8× 188 1.9× 75 0.8× 105 1.2× 59 699
Zhiguo Wang China 18 287 2.0× 356 3.4× 136 1.4× 151 1.6× 154 1.7× 65 1.1k
Hamed Afkhami Iran 20 99 0.7× 400 3.8× 100 1.0× 109 1.1× 132 1.5× 84 1.1k
Meiyu Bao China 10 99 0.7× 130 1.2× 120 1.2× 58 0.6× 100 1.1× 13 462

Countries citing papers authored by Jing Deng

Since Specialization
Citations

This map shows the geographic impact of Jing Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Deng more than expected).

Fields of papers citing papers by Jing Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Deng. The network helps show where Jing Deng may publish in the future.

Co-authorship network of co-authors of Jing Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Deng. A scholar is included among the top collaborators of Jing Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Deng. Jing Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tingting, Zhi Zhang, Jing Deng, et al.. (2025). CXCL16 knockout inhibit asthma airway inflammation by suppressing H2-DM molecular mediated antigen presentation. Cell Death Discovery. 11(1). 90–90. 1 indexed citations
2.
Yin, Wenjun, Junyang Xiao, Jie Dong, et al.. (2024). Peracetic acid activation by chitosan-derived nitrogen-doped carbon spheres loaded with zero-valent copper for efficient sulfamethazine degradation in groundwater. Separation and Purification Technology. 358. 130291–130291. 5 indexed citations
3.
Geng, Jingshu, Zhiqiang Yu, Wenxu Sun, et al.. (2024). 14 (PB002): Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy. European Journal of Cancer. 211. 114543–114543. 2 indexed citations
4.
Zhou, Bingqian, et al.. (2022). Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics. Bioactive Materials. 23. 80–100. 31 indexed citations
5.
Liu, Lubin, Zhanyi Sun, Yanjing Ji, et al.. (2021). Fucoidan as a marine-origin prebiotic modulates the growth and antibacterial ability of Lactobacillus rhamnosus. International Journal of Biological Macromolecules. 180. 599–607. 66 indexed citations
6.
Wang, Zheng, et al.. (2021). Biomaterial-based encapsulated probiotics for biomedical applications: Current status and future perspectives. Materials & Design. 210. 110018–110018. 61 indexed citations
7.
He, Yun, Wenwen Zhao, Yanjing Ji, et al.. (2020). A biodegradable antibacterial alginate/carboxymethyl chitosan/Kangfuxin sponges for promoting blood coagulation and full-thickness wound healing. International Journal of Biological Macromolecules. 167. 182–192. 154 indexed citations
9.
Xiao, Hong, Wen‐Liang Huang, Kainan Xiong, et al.. (2019). Osteochondral repair using scaffolds with gradient pore sizes constructed with silk fibroin, chitosan, and nano-hydroxyapatite. SHILAP Revista de lepidopterología. 2 indexed citations
10.
Ruan, Wenjing, et al.. (2019). Novel Aspects of Insulin-like Growth Factor 1/insulin Network in Chronic Inflammatory Airway Disease. Current Medicinal Chemistry. 27(42). 7256–7263. 2 indexed citations
11.
Zhang, Hongzhe, Lingshuang Liu, Chunmiao Jiang, et al.. (2019). MMP9 protects against LPS-induced inflammation in osteoblasts. Innate Immunity. 26(4). 259–269. 59 indexed citations
12.
Fang, Weijia, Yun Luo, Caiyun Fu, et al.. (2014). Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China. BMC Infectious Diseases. 14(1). 523–523. 27 indexed citations
13.
Ding, Kai, Jing Deng, Kaifang Du, et al.. (2012). SU‐D‐BRB‐05: Small Animal Lung Compliance Imaging: Assessment System for Tissue Sensitivity to Radiation Induced Lung Injury. Medical Physics. 39(6Part3). 3615–3615. 1 indexed citations
15.
Ji, Qiu Xia, Qing Zhao, Jing Deng, & Rui Lü. (2010). A novel injectable chlorhexidine thermosensitive hydrogel for periodontal application: preparation, antibacterial activity and toxicity evaluation. Journal of Materials Science Materials in Medicine. 21(8). 2435–2442. 63 indexed citations
16.
Bao, Han, Wei Fang, Jin Chen, et al.. (2010). Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin. Cancer Chemotherapy and Pharmacology. 67(1). 147–152. 2 indexed citations
17.
Ji, Qiu Xia, et al.. (2010). Biocompatibility of a chitosan-based injectable thermosensitive hydrogel and its effects on dog periodontal tissue regeneration. Carbohydrate Polymers. 82(4). 1153–1160. 66 indexed citations
18.
Weng, Xiufang, Zhihui Liang, Xiaoling Lü, et al.. (2007). Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2. Science in China Series C Life Sciences. 50(2). 203–211. 4 indexed citations
19.
Deng, Jing, et al.. (2007). The Role of Toll-Like Receptors 2 and 4 in Acute Allograft Rejection After Liver Transplantation. Transplantation Proceedings. 39(10). 3222–3224. 41 indexed citations
20.
Deng, Jing & Jie Jin. (2005). [Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism].. PubMed. 13(3). 434–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026